Cargando…
Deficiency of optineurin enhances osteoclast differentiation by attenuating the NRF2-mediated antioxidant response
Abnormally increased resorption contributes to bone degenerative diseases such as Paget’s disease of bone (PDB) through unclear mechanisms. Recently, the optineurin (OPTN) gene has been implicated in PDB, and global OPTN knockout mice (Optn(−/−)) were shown to exhibit increased formation of osteocla...
Autores principales: | Xue, Peng, Hu, Xiangxiang, Chang, Emily, Wang, Lufei, Chen, Minghui, Wu, Tai-Hsien, Lee, Dong-Joon, Foster, Brian L., Tseng, Henry C., Ko, Ching-Chang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102640/ https://www.ncbi.nlm.nih.gov/pubmed/33864025 http://dx.doi.org/10.1038/s12276-021-00596-w |
Ejemplares similares
-
Optineurin regulates NRF2-mediated antioxidant response in a mouse model of Paget’s disease of bone
por: Hu, Xiangxiang, et al.
Publicado: (2023) -
Optineurin Negatively Regulates Osteoclast Differentiation by Modulating NF-κB and Interferon Signaling: Implications for Paget’s Disease
por: Obaid, Rami, et al.
Publicado: (2015) -
Optineurin Functions for Optimal Immunity
por: Slowicka, Karolina, et al.
Publicado: (2018) -
Optineurin Deficiency and Insufficiency Lead to Higher Microglial TDP-43 Protein Levels
por: Prtenjaca, Nikolina, et al.
Publicado: (2022) -
Novel mutation in optineurin causing aggressive ALS+/−frontotemporal dementia
por: Feng, Shu‐Man, et al.
Publicado: (2019)